Loading...

PTHS PELTHOS THERAPEUTICS INC IPO Launches 8-K Filing

PLTH

PTHS

PELTHOS THERAPEUTICS INC

(PTHS)

2024 8-K

Show Summary

Summary

Financial Results Update

Merger of Equals

Regulatory Compliance

Merger Agreement

Promissory Note

Corporate Merger

Corporate Merger

Annual Meeting Results

Stock Repurchase Plan

Convertible Note Financing ...

Appointment of CEO

Conference Presentation

External Links:

Chromocell Therapeutics Corp entered into an underwriting agreement for an IPO, listing its common stock on NYSE American and raising approximately $6.6 million in net proceeds.

AI Assistant

PELTHOS THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.